HOME >> MEDICINE >> NEWS
First-ever conference on depression in college students to be held March 6-7 in Michigan

ANN ARBOR, MI The University of Michigan will host the nation's first major conference focused on depression in college students, on March 6 and 7 at the Michigan League in Ann Arbor, MI.

The event will explore current knowledge on depression and related disorders in college undergraduate and graduate students, and the best approaches for prevention, detection and treatment. It is co-sponsored by the U-M Depression Center -- the only center in the nation devoted to research, treatment and education on all forms of depression -- and the U-M Rackham School of Graduate Studies.

Educators, students, researchers, mental health advocates and professionals, and the media are welcome to attend. Space is limited and registration is required; a registration fee will be charged for all participants except students and journalists. For more information, visit www.rackham.umich.edu/DepressionConf and www.depressioncenter.org.

Speakers will include depression experts from the U-M and other academic institutions, mental health advocates, and students who have dealt with depression and bipolar disorder in their own lives. The event will feature many workshops and discussion groups, as well as panel sessions, displays, a video documentary featuring students with depression, and a performance by Mentality, a U-M student advocacy group that explores mental health issues.

Three noted authors whose books address their own experiences with depression will give keynote addresses open to the public: National Book Award winner Andrew Solomon, author of "The Noonday Demon"; Meri Nana-Ama Danquah, who wrote "Willow Weep for Me: A Black Woman's Journey Though Depression", and Kathy Cronkite, author of "On the Edge of Darkness: Conversations About Conquering Depression", which features interviews with celebrities who have depression.

"Awareness of dep
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
7-Feb-2003


Page: 1 2 3

Related medicine news :

1. First-ever safety study of medical cannabis use in Canada launched
2. How 9/11 changed us: First-ever quantitative research documents the before and after effect
3. Massive weight loss conference Dallas April 1-2
4. Protecting human subjects focus of national FDA conference at UH
5. Is your job giving you a heart attack? Occupational health conference answers that, and more
6. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
7. US cancer researchers launch first American-Israeli cancer conference
8. State of the heart news conference
9. Audio conference: Insulin resistance and polycystic ovary syndrome
10. IU Medical School poised to host global HIV/AIDS conference
11. NIH convenes state-of-the-science conference on preventing youth violence

Post Your Comments:
(Date:6/19/2013)... 19, 2013 Maui'd Forever , ... to being an effective and cost effective way to ... have partnered up with Tom Barefoot’s Tours providing an ... most of Hawaii’s activities. , They have just released ... get the lowest prices on their Hawaii activities. ...
(Date:6/19/2013)... 2013 According to Transparency Market Research ... Trends, Analysis and Forecast, 2011 – 2017,” the global ... the year 2011 and is expected to reach USD ... 9.7% from 2011 to 2017. Flexible endoscopes formed the ... USD 2,201 million for the year 2011. , Related ...
(Date:6/19/2013)... treating stroke victims has been "time equals brain." That,s because ... a drug that dissolves the stroke-causing blood clot can make ... or lost. , But specific information has been ... drug known as a tissue plasminogen activator, or tPA ... most common type of stroke. , Now, a ...
(Date:6/19/2013)... MAYWOOD, Il. A Loyola University Chicago Niehoff School ... grant to study whether Vitamin D can improve mood ... study also will examine whether vitamin D supplementation can ... their diabetes. The grant is from the National Institute ... , Principal investigator Sue M. Penckofer, PhD, RN and ...
(Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud to ... newly-designed Harley Davidson motorcycle gas tank. A couple of weeks ... idea of taking a split tank motorcycle that had been ... into a work of art. , In October of ... seats that had been dipped in a water transfer printer ...
Breaking Medicine News(10 mins):Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2
(Date:6/19/2013)... , June 19, 2013 NeuroDerm, ... study in volunteers, and preliminary results from a phase ... presented at the 2013 International Congress of Parkinson,s Disease ... drug formula under development for continuous administration through a ... plasma concentrations. ND0612 has been shown in ...
(Date:6/19/2013)... N.J. , June 19, 2013 /PRNewswire-iReach/ ... Pharma, a new specialty pharmaceutical company dedicated ... of innovative injectable and sustained release drug ... unmet medical needs, today announced the acquisition ... Linker Technology®) platform and associated product pipeline. ...
(Date:6/19/2013)... Calif. , June 19, 2013 ... management solutions, introduced the next-generation of its ... which allows health plans to provide their employer ... populations, health factors, medical and prescription drug claims, ... (Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2
Cached News: